Mainstream

Regeneron nabs FDA label expansion for Ultragenyx-partnered cholesterol drug

Regeneron nabs FDA label expansion for Ultragenyx-partnered cholesterol drug

Post Contentregn, rareRead More

You might also be interested in reading Chinese chip designer reportedly filed for $50M Nasdaq IPO.

September 26, 2025
In Mainstream